Clinical Trial Update: Study of Olutasidenib and Temozolomide in HGG [Phase 2]

View source ↗

Summary

Phase 2 study evaluating olutasidenib in combination with temozolomide for high-grade gliomas is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Brain Tumor
• Diffuse Intrinsic Pontine Glioma
• Diffuse Midline Glioma H3 K27-altered
• Glioblastoma
• High-grade Glioma
• Idh-mutant Glioma
• Oligodendroglioma

Drugs mentioned

• Olutasidenib (olutasidenib)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Rigel Pharmaceuticals | Conditions: High Grade Glioma, Astrocytoma | Phase 2 | Status: RECRUITING